Skip to content

Study of magnetic brain stimulation and memory, attention, and reasoning in students

Effect of Transcranial Magnetic Stimulation on cognitive performance in students

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-1068g8pp
Enrollment
120
Registered
2025-05-05
Start date
2025-02-03
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&apos

Interventions

This is a randomized, double-blind, sham-controlled clinical trial in adults aged 18 to 80 years, conducted in three clinical cohorts: adults without neurological comorbidities, patients with Parkinso

Sponsors

Clínica Sinedor Ltda
Lead Sponsor
Palm Serviços Médicos Ltda
Collaborator
Universidade Federal de Mato Grosso - Campus Sinop
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Adults aged 18 to 80 years, of either sex; individuals without neurological comorbidities or with a clinical diagnosis of Parkinson’s disease or Alzheimer’s disease; ability to undergo the planned cognitive assessments and transcranial magnetic stimulation procedures; agreement to participate by signing the informed consent form, directly or through a legal representative when applicable

Exclusion criteria

Exclusion criteria: History of epilepsy or unprovoked seizures; severe or unstable clinical conditions that contraindicate participation in the study; contraindications to transcranial magnetic stimulation identified on clinical screening or according to device safety recommendations; inability to complete the proposed assessments or stimulation procedures; refusal to sign the informed consent form, directly or through a legal representative when applicable

Design outcomes

Primary

MeasureTime frame
Change in cognitive performance and sleep quality from baseline to immediately after the 20th stimulation session, assessed through validated neuropsychological tests and the Pittsburgh Sleep Quality Index (PSQI), according to the participant’s clinical cohort.

Secondary

MeasureTime frame
Occurrence, frequency, and severity of adverse events related to the intervention, evaluated throughout the stimulation sessions and follow-up period, in order to assess the safety and tolerability of transcranial magnetic stimulation.;Subjective perception of changes related to the intervention, including perceived cognitive performance, sleep quality, attention, concentration, well-being, and performance in daily activities, assessed through participant-reported measures.

Countries

BR

Contacts

Public ContactGuilherme de Paula

Universidade Federal de Mato Grosso - Campus Sinop

gui_oliveira.16@hotmail.com+55(66)99913-7819

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: May 1, 2026